1.河南中医药大学第一附属医院,河南省郑州市金水区人民路19号,450000
2.河南中医药大学
wangxinlu110@126.com
收稿:2024-08-28,
修回:2024-11-09,
纸质出版:2025-03-17
移动端阅览
韩文杰,朱明军,王新陆等.冠心病稳定型心绞痛患者再入院中西医风险预测模型构建与应用评估——基于真实世界临床数据的前瞻性研究[J].中医杂志,2025,66(06):604-611.
HAN Wenjie,ZHU Mingjun,WANG Xinlu,et al.Construction and Application Evaluation of an Integrated Traditional Chinese and Western Medicine Risk Prediction Model for Readmission in Patients with Stable Angina of Coronary Heart Disease:A Prospective Study Based on Real-World Clinical Data[J].Journal of Traditional Chinese Medicine,2025,66(06):604-611.
韩文杰,朱明军,王新陆等.冠心病稳定型心绞痛患者再入院中西医风险预测模型构建与应用评估——基于真实世界临床数据的前瞻性研究[J].中医杂志,2025,66(06):604-611. DOI: 10.13288/j.11-2166/r.2025.06.010.
HAN Wenjie,ZHU Mingjun,WANG Xinlu,et al.Construction and Application Evaluation of an Integrated Traditional Chinese and Western Medicine Risk Prediction Model for Readmission in Patients with Stable Angina of Coronary Heart Disease:A Prospective Study Based on Real-World Clinical Data[J].Journal of Traditional Chinese Medicine,2025,66(06):604-611. DOI: 10.13288/j.11-2166/r.2025.06.010.
目的
2
基于真实世界临床数据探讨冠心病稳定型心绞痛患者再入院的影响因素,建立中西医风险预测模型,以期为早期识别高风险人群、降低患者再入院率提供依据。
方法
2
采用前瞻性临床研究方法,纳入冠心病稳定型心绞痛患者按照7∶3的比例分为训练集和验证集。统一采集其一般信息、中医资料、实验室检查等相关信息,随访1年后根据是否发生再入院事件分为再入院组和非再入院组。采用单因素Logistic回归和多因素Logistic回归分析筛选冠心病稳定型心绞痛再入院的独立影响因素,构建再入院中西医风险预测模型,并通过列线图进行可视化展示。分别从区分度、校准度、临床决策曲线方面对模型进行验证和评价。
结果
2
共纳入分析682例患者,训练集477例,验证集205例,共有89例患者发生再入院。多因素Logistic回归分析发现,心力衰竭病史[
OR
=6.93,95%
CI
(1.58,30.45)]、弦脉[
OR
=2.58,95%
CI
(1.42,4.72)]、虚脉[
OR
=3.97,95%
CI
(2.06,7.67)]、齿痕舌[
OR
=4.38,95%
CI
(2.32,8.27)]、血瘀质[
OR
=2.17,95%
CI
(1.06,4.44)]、痰瘀互结证[
OR
=3.64,95%
CI
(1.87,7.09)]、非高密度脂蛋白胆固醇升高[
OR
=1.30,95%
CI
(1.01,1.69)]为冠心病稳定型心绞痛患者再入院的影响因素。基于以上筛选出的影响因素作为模型的最终预测因子,构建冠心病稳定型心绞痛再入院风险列线图,该模型显示出中等预测能力。模型验证结果显示,在建模人群中受试者工作特征曲线下面积(AUC)为0.818[95%
CI
(0.781,0.852)],在验证人群中AUC为0.816[95%
CI
(0.779,0.850)]。Hosmer-Lemeshow检验结果表明,模型的区分度较好(
χ
2
=4.55,
P
=0.80),且预测能力较稳定。阈值概率>5%时该模型预测冠心病稳定型心绞痛患者再入院风险的临床净获益显著高于对所有患者实施干预。
结论
2
心力衰竭病史、齿痕舌、虚脉、弦脉、痰瘀互结证、血瘀质、非高密度脂蛋白胆固醇是冠心病稳定型心绞痛患者再入院的影响因素,并以此建立了临床预测模型。该模型具有良好的区分度、校准度以及临床有效性,能为预测稳定型心绞痛患者发生再入院事件提供科学依据。
Objective
2
By exploring the influencing factors of readmission in patients with stable angina of coronary heart disease (CHD) based on real-world clinical data, to establish a risk prediction model of integrated traditional Chinese and western medicine, in order to provide a basis for early identification of high-risk populations and reducing readmission rates.
Methods
2
A prospective clinical study was conducted involving patients with stable angina pectoris of CHD, who were divided into a training set and a validation set at a 7∶3 ratio. General information, traditional Chinese medicine (TCM)-related data, and laboratory test results were uniformly collected. After a one-year follow-up, patients were classified into a readmission group and a non-readmission group based on whether they were readmitted. Univariate and multivariate logistic regression analyses were performed to identify independent risk factors for readmission. A risk prediction model of integrated traditional Chinese and western medicine was constructed and visualized using a nomogram. The model was validated and evaluated in terms of discrimination, calibration, and clinical decision curve analysis.
Results
2
A total of 682 patients were included, with 477 in the training set and 205 in the validation set, among whom 89 patients were readmitted. Multivariate logistic regression analysis identified heart failure history [
OR
= 6.93, 95%
CI
(1.58, 30.45)], wiry pulse [
OR
= 2.58, 95%
CI
(1.42, 4.72)], weak pulse [
OR
= 3.97, 95%
CI
(2.06, 7.67)], teeth-marked tongue [
OR
= 4.38, 95%
CI
(2.32, 8.27)], blood stasis constitution [
OR
= 2.17, 95%
CI
(1.06, 4.44)], phlegm-stasis mutual syndrome [
OR
= 3.64, 95%
CI
(1.87, 7.09)], and elevated non-high-density lipoprotein cholesterol [
OR
= 1.30, 95%
CI
(1.01, 1.69)] as influencing factors of readmission. These factors were used as predictor
s to construct a nomogram-based risk prediction model for readmission in patients with stable angina. The model demonstrated moderate predictive capability, with an area under the receiver operating characteristic curve (AUC) of 0.818 [95%
CI
(0.781, 0.852)] in the training set and 0.816 [95%
CI
(0.779, 0.850)] in the validation set. The Hosmer-Lemeshow test showed good calibration (χ² = 4.55,
P
= 0.80), and the model's predictive ability was stable. When the threshold probability exceeded 5%, the clinical net benefit of using the model to predict readmission risk was significantly higher than intervening in all patients.
Conclusion
2
History of heart failure, teeth-marked tongue, weak pulse, wiry pulse, phlegm-stasis mutual syndrome, blood stasis constitution, and non-high-density lipoprotein cholesterol are influencing factors for readmission in patients with stable angina of CHD. A clinical prediction model was developed based on these factors, which showed good discrimination, calibration, and clinical utility, providing a scientific basis for predicting readmission events in patients with stable angina.
中国心血管健康与疾病报告编写组 . 中国心血管健康与疾病报告2020概要 [J]. 中国循环杂志 , 2021 , 36 ( 6 ): 521 - 545 .
林果为 , 王吉耀 , 葛均波 . 实用内科学 [M]. 北京 : 人民卫生出版社 , 2017 : 233 - 234 .
于瑞 , 赵英强 , 李鹏 , 等 . 1061例冠心病稳定型心绞痛患者二级预防现状及影响因素的横断面研究 [J]. 中医杂志 , 2024 , 65 ( 20 ): 2126 - 2134 .
FOX KA , DABBOUS OH , GOLDBERG RJ , et al . Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study(GRACE) [J]. BMJ , 2006 , 333 ( 7578 ): 1091 .
CHAITOW L . Clinical prediction rules [J]. J Bodyw Mov Ther , 2010 , 14 ( 3 ): 207 - 208 .
MOONS KG , ROYSTON P , VERGOUWE Y , et al . Prognosis and prognostic research: what, why, and how? [J]. BMJ , 2009 , 338 : b375 . doi: 10.1136/bmj.b375 http://dx.doi.org/10.1136/bmj.b375 .
VAN SMEDEN M , REITSMA JB , RILEY RD , et al . Clinical prediction models: diagnosis versus prognosis [J]. J Clin Epidemiol , 2021 , 132 : 142 - 145 . doi: 10. 1016/j.jclinepi.2021.01.009 http://dx.doi.org/10.1016/j.jclinepi.2021.01.009 .
王薇 , 曹璐 , 任鹏 , 等 . 不同中药注射液联合常规西药治疗稳定型心绞痛的网状Meta分析 [J]. 中国中药杂志 , 2023 , 48 ( 6 ): 1652 - 1663 .
中华医学会心血管病学分会介入心脏病学组 , 中华医学会心血管病学分会动脉粥样硬化与冠心病学组 , 中国医师协会心血管内科医师分会血栓防治专业委员会 , 等 . 稳定性冠心病诊断与治疗指南 [J]. 中华心血管病杂志 , 2018 , 46 ( 9 ): 680 - 694 .
中华中医药学会心血管病分会 . 冠心病稳定型心绞痛中医诊疗指南 [J]. 中医杂志 , 2019 , 60 ( 21 ): 1880 - 1890 .
王阶 , 邢雁伟 . 冠心病心绞痛证候要素诊断标准 [J]. 中医杂志 , 2018 , 59 ( 6 ): 539 - 540 .
郑筱萸 . 中药新药临床研究指导原则(试行) [M]. 北京 : 中国医药科技出版社 , 2002 : 68 - 73 .
中华中医药学会 . 中医体质分类与判定(ZYYXH/T157-2009) [J]. 世界中西医结合杂志 , 2009 , 4 ( 4 ): 303 - 304 .
SCHWINGSHACKL L , KNÜPPEL S , MICHELS N , et al . Intake of 12 food groups and disability-adjusted life years from coronary heart disease, stroke, type 2 diabetes, and colorectal cancer in 16 European countries [J]. Eur J Epidemiol , 2019 , 34 ( 8 ): 765 - 775 .
裘淼涵 , 边丽雅 , 方楚嫒 , 等 . 基于SYNTAX血运重建指数评价置入生物可降解涂层药物洗脱支架冠心病患者的长期临床预后 [J]. 中华心血管病杂志 , 2019 , 47 ( 10 ): 790 - 797 .
费敏 , 雷思 , 许琰 , 等 . 阻塞性睡眠呼吸暂停低通气综合征对高血压患者血压变异性和心率变异性的影响研究 [J]. 中国全科医学 , 2023 , 26 ( 20 ): 2459 - 2468 .
张赤道 , 黄金雨 , 王永霞 , 等 . 中成药治疗急性心肌梗死后心力衰竭的临床研究证据图分析 [J]. 中国中药杂志 , 2024 , 49 ( 6 ): 1673 - 1682 .
蔡贞浩 , 戴国华 , 张嘉禛 , 等 . 芪参益气滴丸治疗慢性心力衰竭患者终点事件发生情况的队列研究 [J]. 西部中医药 , 2022 , 35 ( 12 ): 118 - 121 .
王增武 , 郭远林 . 中国血脂管理指南(基层版2024年) [J]. 中国循环杂志 , 2024 , 39 ( 4 ): 313 - 321 .
CHEN L , CHEN S , BAI X , et al . Low-density lipoprotein cholesterol, cardiovascular disease risk, and mortality in China [J]. JAMA Netw Open , 2024 , 7 ( 7 ): e2422558 .
李华 . 非高密度脂蛋白胆固醇达标情况与冠心病患者介入治疗预后的关系 [J]. 中国卫生工程学 , 2023 , 22 ( 5 ): 695 - 697 .
AMAD H , YAN AT , YAN RT , et al . The association between prior use of aspirin and/or warfarin and the in-hospital management and outcomes in patients presenting with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events(GRACE) [J]. Can J Cardiol , 2012 , 28 ( 1 ): 48 - 53 .
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号